Startup
TTTypewriter Therapeutics
タイプライター・セラピューティクス
#50 in the Japan Top 100 Startups
| Founded / HQ | 2022 · Tokyo |
|---|---|
| Equity raised to date | ≥ ¥9B “シリーズAで5,600万ドル（約90億円）” Company-stated cumulative · as of 2 Sept 2026 · Typewriter Therapeutics Only the Series A is confirmed; an earlier ~$5M raise was reported. |
| Last round | 2 Sept 2026 · Series A · ¥9B 5,600万ドル（約90億円） |
| Latest public valuation | Not publicly disclosed (we do not estimate) |
| Key investors | AN Venture Partners, RA Capital Management |
| Unicorn | No |
| Website | typewritertx.com |
Overview
Typewriter Therapeutics develops gene-editing therapies. Founded in 2022, it raised a $5M seed round in February 2024 and a $56M Series A in September 2026.
Built from: Series A (ANRI)
Company timeline
Founded
| Date | 2022-02· Typewriter team page |
|---|---|
| Founders | Haruhiko Fujiwara |
Funding
| Date | Round | Amount | Lead / key investors | Source |
|---|---|---|---|---|
| 2024-02-27 | Seed | $5M 500万ドル | AN Venture Partners, RA Capital Management | JCN Newswire via IPROS |
| 2026-09-02 | Series A | $56M シリーズAで5,600万ドル | ANRI |
Key hires & board
None compiled yet.
Milestones
None compiled yet.
News
| 2026-09-02 | Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines· Typewriter |
|---|---|
| 2026-09-02 | Series A: $56M· ANRI |
| 2024-02-27 | Seed: $5M· JCN Newswire via IPROS |
Funding rounds in 2026
No 2026 rounds in our database yet. Earlier funding is summarised above from the cited source.